Merck Company Foundation
The African Comprehensive HIV/AIDS Partnerships (ACHAP) is an initiative of the Republic of Botswana, along with MSD /Merck Company Foundation and the Bill & Melinda Gates Foundation, to demonstrate the feasibility of a comprehensive country-led approach to improving the entire spectrum of HIV/AIDS prevention, care and treatment in Botswana.
Merck’s first responsibility in our fight against HIV/AIDS is to continue doing what we do best: to marshal our expertise and capacity in cutting-edge science to discover and develop breakthrough medicines and vaccines that will save lives and spare human suffering.
This means continued dedication to a research effort begun in 1986 that has yielded two imported medicines to date. More importantly, we continue to pursue a vaccine that we believe will offer the best hope for people living HIV worldwide.
The second responsibility of companies like ours in confronting the globalization of HIV/AIDS is to continue doing what we must to champion public/private partnerships that bring co-ordinated response to working with the government and our partners to improve prevention, care and treatment. In Botswana, we are working with the government and our partners to improve prevention, care and treatment for HIV/AIDS, including training, education, testing, counseling and medical care.
It is a country-led process: their priorities, their needs - leveraging our resources, experience and commitment to help. By working together, pooling our knowledge and resources, we can mount effective solutions to this critical challenge- and make a world of difference for people in Botswana and millions of people around the world living with HIV/AIDS today.